Correlation Between Assembly Biosciences and Century Therapeutics
Can any of the company-specific risk be diversified away by investing in both Assembly Biosciences and Century Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Assembly Biosciences and Century Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Assembly Biosciences and Century Therapeutics, you can compare the effects of market volatilities on Assembly Biosciences and Century Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Assembly Biosciences with a short position of Century Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Assembly Biosciences and Century Therapeutics.
Diversification Opportunities for Assembly Biosciences and Century Therapeutics
0.26 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Assembly and Century is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Assembly Biosciences and Century Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Century Therapeutics and Assembly Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Assembly Biosciences are associated (or correlated) with Century Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Century Therapeutics has no effect on the direction of Assembly Biosciences i.e., Assembly Biosciences and Century Therapeutics go up and down completely randomly.
Pair Corralation between Assembly Biosciences and Century Therapeutics
Given the investment horizon of 90 days Assembly Biosciences is expected to generate 0.83 times more return on investment than Century Therapeutics. However, Assembly Biosciences is 1.2 times less risky than Century Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Century Therapeutics is currently generating about 0.04 per unit of risk. If you would invest 1,583 in Assembly Biosciences on September 1, 2024 and sell it today you would earn a total of 121.00 from holding Assembly Biosciences or generate 7.64% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Assembly Biosciences vs. Century Therapeutics
Performance |
Timeline |
Assembly Biosciences |
Century Therapeutics |
Assembly Biosciences and Century Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Assembly Biosciences and Century Therapeutics
The main advantage of trading using opposite Assembly Biosciences and Century Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Assembly Biosciences position performs unexpectedly, Century Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Century Therapeutics will offset losses from the drop in Century Therapeutics' long position.Assembly Biosciences vs. Spero Therapeutics | Assembly Biosciences vs. Achilles Therapeutics PLC | Assembly Biosciences vs. Instil Bio | Assembly Biosciences vs. CytomX Therapeutics |
Century Therapeutics vs. Edgewise Therapeutics | Century Therapeutics vs. C4 Therapeutics | Century Therapeutics vs. Mineralys Therapeutics, Common | Century Therapeutics vs. Cullinan Oncology LLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |